Charmaine Demanuele

Charmaine Demanuele

Auto-generated profile, based on publicly available information

Charmaine Demanuele

Pfizer (United States), Cambridge, US

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2023 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
MGMercedeh Ghadessi
Mercedeh Ghadessi
JDJunrui Di
Junrui Di
CWChenkun Wang
Chenkun Wang
KTKiichiro Toyoizumi
Kiichiro Toyoizumi
NSNan Shao
Nan Shao
RBRobert A. Beckman
Robert A. Beckman
Background: Traditional clinical trials require tests and procedures that are administered in centralized clinical research sites, which are beyond the standard of care that patients receive for their rare and chronic diseases. The limited number of rare disease patients scattered around the world makes it particularly challenging to recruit participants and conduct these traditional clinical trials. Main body: Participating in clinical research can be burdensome, especially for children, the elderly, physically and cognitively impaired individuals who require transportation and caregiver assistance, or patients who live in remote locations or cannot afford transportation. In recent years, there is an increasing need to consider Decentralized Clinical Trials (DCT) as a participant-centric approach that uses new technologies and innovative procedures for interaction with participants in the comfort of their home. Conclusion: This paper discusses the planning and conduct of DCTs, which can increase the quality of trials with a specific focus on rare diseases.

21 October 2020 in JMIR Rehabilitation and Assistive Technologies
Verified
Journal Article
Open access
MCMatthew Daniel Czech
Matthew Daniel Czech
CDCharmaine Demanuele
Charmaine Demanuele
MEMichael Kelley Erb
Michael Kelley Erb
VRVesper Ramos
Vesper Ramos
HZHao Zhang
Hao Zhang
SPShyamal Patel
Shyamal Patel
Background: Measuring free-living gait using wearable devices may offer higher granularity and temporal resolution than the current clinical assessments for patients with Parkinson disease (PD). However, increasing the number of devices worn on the body adds to the patient burden and impacts the compliance. Objective: This study aimed to investigate the impact of reducing the number of wearable devices on the ability to assess gait impairments in patients with PD. Methods: A total of 35 volunteers with PD and 60 healthy volunteers performed a gait task during 2 clinic visits. Participants with PD were assessed in the On and Off medication state using the Movement Disorder Society version of the Unified Parkinson Disease Rating Scale (MDS-UPDRS). Gait features derived from a single lumbar-mounted accelerometer were compared with those derived using 3 and 6 wearable devices for both participants with PD and healthy participants. Results: A comparable performance was observed for predicting the MDS-UPDRS gait score using longitudinal mixed-effects model fit with gait features derived from a single (root mean square error [RMSE]=0.64; R2=0.53), 3 (RMSE=0.64; R2=0.54), and 6 devices (RMSE=0.54; R2=0.65). In addition, MDS-UPDRS gait scores predicted using all 3 models differed significantly between On and Off motor states (single device, P=.004; 3 devices, P=.004; 6 devices, P=.045). Conclusions: We observed a marginal benefit in using multiple devices for assessing gait impairments in patients with PD when compared with gait features derived using a single lumbar-mounted accelerometer. The wearability burden associated with the use of multiple devices may offset gains in accuracy for monitoring gait under free-living conditions.

19 November 2020 in Sensors
Verified
Journal Article
Open access
PDF file
LALukas Adamowicz
Lukas Adamowicz
FKF. Isik Karahanoglu
F. Isik Karahanoglu
CCChristopher Cicalo
Christopher Cicalo
HZHao Zhang
Hao Zhang
CDCharmaine Demanuele
Charmaine Demanuele
SPShyamal Patel
Shyamal Patel
The ability to perform sit-to-stand (STS) transfers has a significant impact on the functional mobility of an individual. Wearable technology has the potential to enable the objective, long-term monitoring of STS transfers during daily life. However, despite several recent efforts, most algorithms for detecting STS transfers rely on multiple sensing modalities or device locations and have predominantly been used for assessment during the performance of prescribed tasks in a lab setting. A novel wavelet-based algorithm for detecting STS transfers from data recorded using an accelerometer on the lower back is presented herein. The proposed algorithm is independent of device orientation and was validated on data captured in the lab from younger and older healthy adults as well as in people with Parkinson’s disease (PwPD). The algorithm was then used for processing data captured in free-living conditions to assess the ability of multiple features extracted from STS transfers to detect age-related group differences and assess the impact of monitoring duration on the reliability of measurements. The results show that performance of the proposed algorithm was comparable or significantly better than that of a commercially available system (precision: 0.990 vs. 0.868 in healthy adults) and a previously published algorithm (precision: 0.988 vs. 0.643 in persons with Parkinson’s disease). Moreover, features extracted from STS transfers at home were able to detect age-related group differences at a higher level of significance compared to data captured in the lab during the performance of prescribed tasks. Finally, simulation results showed that a monitoring duration of 3 days was sufficient to achieve good reliability for measurement of STS features. These results point towards the feasibility of using a single accelerometer on the lower back for detection and assessment of STS transfers during daily life. Future work in different patient populations is needed to evaluate the performance of the proposed algorithm, as well as assess the sensitivity and reliability of the STS features.

1 September 2022 in Sensors
Verified
Journal Article
Open access
PDF file
DPDimitrios John Psaltos
Dimitrios John Psaltos
FMFahimeh Mamashli
Fahimeh Mamashli
TATomasz Adamusiak
Tomasz Adamusiak
CDCharmaine Demanuele
Charmaine Demanuele
MSMar Santamaria
Mar Santamaria
MCMatthew Daniel Czech
Matthew Daniel Czech
Stair climb power (SCP) is a clinical measure of leg muscular function assessed in-clinic via the Stair Climb Power Test (SCPT). This method is subject to human error and cannot provide continuous remote monitoring. Continuous monitoring using wearable sensors may provide a more comprehensive assessment of lower-limb muscular function. In this work, we propose an algorithm to classify stair climbing periods and estimate SCP from a lower-back worn accelerometer, which strongly agrees with the clinical standard (r = 0.92, p < 0.001; ICC = 0.90, [0.82, 0.94]). Data were collected in-lab from healthy adults (n = 65) performing the four-step SCPT and a walking assessment while instrumented (accelerometer + gyroscope), which allowed us to investigate tradeoffs between sensor modalities. Using two classifiers, we were able to identify periods of stair ascent with >89% accuracy [sensitivity = >0.89, specificity = >0.90] using two ensemble machine learning algorithms, trained on accelerometer signal features. Minimal changes in model performances were observed using the gyroscope alone (±0–6% accuracy) versus the accelerometer model. While we observed a slight increase in accuracy when combining gyroscope and accelerometer (about +3–6% accuracy), this is tolerable to preserve battery life in the at-home environment. This work is impactful as it shows potential for an accelerometer-based at-home assessment of SCP.

18 October 2023 in Sensors
Verified
Journal Article
Open access
PDF file
WLWenyi Lin
Wenyi Lin
FKFikret Isik Karahanoglu
Fikret Isik Karahanoglu
DPDimitrios John Psaltos
Dimitrios John Psaltos
LALukas Adamowicz
Lukas Adamowicz
MSMar Santamaria
Mar Santamaria
JDJunrui Di
Junrui Di
Wearable accelerometers allow for continuous monitoring of function and behaviors in the participant’s naturalistic environment. Devices are typically worn in different body locations depending on the concept of interest and endpoint under investigation. The lumbar and wrist are commonly used locations: devices placed at the lumbar region enable the derivation of spatio-temporal characteristics of gait, while wrist-worn devices provide measurements of overall physical activity (PA). Deploying multiple devices in clinical trial settings leads to higher patient burden negatively impacting compliance and data quality and increases the operational complexity of the trial. In this work, we evaluated the joint information shared by features derived from the lumbar and wrist devices to assess whether gait characteristics can be adequately represented by PA measured with wrist-worn devices. Data collected at the Pfizer Innovation Research (PfIRe) Lab were used as a real data example, which had around 7 days of continuous at-home data from wrist- and lumbar-worn devices (GENEActiv) obtained from a group of healthy participants. The relationship between wrist- and lumbar-derived features was estimated using multiple statistical methods, including penalized regression, principal component regression, partial least square regression, and joint and individual variation explained (JIVE). By considering multilevel models, both between- and within-subject effects were taken into account. This work demonstrated that selected gait features, which are typically measured with lumbar-worn devices, can be represented by PA features measured with wrist-worn devices, which provides preliminary evidence to reduce the number of devices needed in clinical trials and to increase patients’ comfort. Moreover, the statistical methods used in this work provided an analytic framework to compare repeated measures collected from multiple data modalities.

12 December 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
LALukas Adamowicz
Lukas Adamowicz
WLWenyi Lin
Wenyi Lin
FKF Isik Karahanoglu
F Isik Karahanoglu
XCXuemei Cai
Xuemei Cai
MSMar Santamaria
Mar Santamaria
JDJunrui Di
Junrui Di
Background: Digital health technologies, such as accelerometry, offer low participant burden and provide quantitative metrics with ease of deployment, making them increasingly popular for gait monitoring. Remote gait monitoring delivers quantifiable, continuous health measures over extended periods, surpassing the limited insights from single clinic or laboratory visits and offering a more comprehensive health perspective. Numerous gait algorithm implementations, inspired by prior research, aim to standardize these metrics across devices. The SciKit Digital Health (SKDH) package exemplifies this as a device-agnostic framework. Objective: This study introduces a series of literature-informed enhancements to the SKDH gait algorithm, improving its performance against reference standards and reducing the need for manual parameter adjustments across diverse populations. Methods: A block-wise refinement process was undertaken, examining each algorithmic component for potential enhancements and evaluating their cumulative impact on the complete gait algorithm and the metrics generated. Results: Using data from healthy adult and pediatric participants, the novel gait event estimation method reduced the mean absolute error by more than 50% compared with its predecessor. Following the updates, the intraclass correlation values for final gait metric concordance with the in-laboratory reference improved markedly, from 0.50-0.74 to 0.81-0.90. Additionally, the systematic bias observed in the previous version’s gait speed estimation was rectified, narrowing the difference from the reference from 0.065-0.230 to 0.00-0.03 m/s. Conclusions: The findings from this study provide robust evidence supporting the validity of the enhancements made to the gait algorithm. They demonstrate that a single lumbar accelerometer can capture gait characteristics with high accuracy and reliability across various speeds and age groups.